TFRC and myelodysplastic syndrome: MDS patients express increased levels of PD-1 and PD-L1 on CD34+ HSPCs and CD71+ erythroid progenitors versus age-matched healthy donors, whereas CD33+CD14+ MDSC express elevated levels of PD-L1 in MDS.